Citizens Financial Group Inc Exagen Inc. Transaction History
Citizens Financial Group Inc
- $7.13 Billion
- Q3 2025
A detailed history of Citizens Financial Group Inc transactions in Exagen Inc. stock. As of the latest transaction made, Citizens Financial Group Inc holds 57,520 shares of XGN stock, worth $532,060. This represents 0.01% of its overall portfolio holdings.
Number of Shares
57,520
Previous 67,600
14.91%
Holding current value
$532,060
Previous $471,000
33.33%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding XGN
# of Institutions
56Shares Held
8.96MCall Options Held
0Put Options Held
0-
Rtw Investments, LP New York, NY1.7MShares$15.7 Million0.18% of portfolio
-
Toronto Dominion Bank Toronto, Ontario, A6851KShares$7.87 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA734KShares$6.79 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL719KShares$6.65 Million0.01% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$4.92 Million0.03% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $150M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...